Carina Biotech
Adelaide, AU · Founded 2016 · 16 employees on LinkedIn · 1 known investors
Find your way into Carina Biotech
Sign up to find every way you can get introduced to Carina Biotech
- Your email: who you already know at Carina Biotech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Carina Biotech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Carina Biotech develops chimeric antigen receptor T cell (CAR-T) therapies and other adoptive cell therapies to treat solid cancers using a patient's immune system. The Australian clinical-stage immunotherapy company creates patient-specific treatments with proprietary platforms designed to improve access to tumors and enhance cell manufacturing.
Founders & leadership
DD

Dr Deborah RathjenChief Executive Officer & Managing Director
PS
Professor Shaun McCollChief Scientific Officer
Board
CB
Claudine BonderHead, Vascular Biology and Cell Trafficking Laboratory
Investors · 1
Tenmilelisted by Tenmile
How we know: labiotech.eu · Not right? Tell us
Frequently asked questions
- What does Carina Biotech do?
- Carina Biotech develops chimeric antigen receptor T cell (CAR-T) therapies and other adoptive cell therapies to treat solid cancers using a patient's immune system. The Australian clinical-stage immunotherapy company creates patient-specific treatments with proprietary platforms designed to improve access to tumors and enhance cell manufacturing.
- Who are Carina Biotech's investors?
- Carina Biotech's investors include Tenmile.
- Where is Carina Biotech headquartered?
- Carina Biotech is headquartered in Adelaide, AU.


